Clinical Trials Market Size, Growth, Demands Outlook and Forecasts to 2030

According to the research report, the global clinicaltrials market size is expected to touch USD 84.43 Billion by 2030, from USD 53.87 Billion in 2022, growing with a significant CAGR of 5.7% from 2022 to 2030.

Clinical Trials Market Size 2020-2030

The clinical trials market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global clinical trials market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global clinical trials market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global clinical trials market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1185

Report Scope of the Clinical Trials Market

Report Highlights	Details
Market Size	USD 84.43 Billion by 2030
Growth Rate	CAGR of 5.7% from 2022 to 2030
Largest Market	North America
Fastest Growing Market	Asia Pacific
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Phase, Study Design, Indication

This study covers a detailed segmentation of the global clinical trials market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global clinical trials market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

Parexel
IQVIA
Charles River Laboratory
Omnicare
Kendle
Chiltern
Pharmaceutical Product Development, LLC

Market Segmentation

By Phase

Phase 1
Phase 2
Phase 3
Phase 4

By Study Design

Observational
Interventional
Expanded Access

By Indication

Autoimmune/Inflammation
- Rheumatoid arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable Bowel Syndrome (IBS)
- Others
Pain Management
- Chronic Pain
- Acute Pain
Oncology
- Blood Cancer
- Solid Tumors
- Other
CNS Condition
- Epilepsy
- Parkinson's Disease (PD)
- Huntington's Disease
- Stroke
- Traumatic Brain Injury (TBI)
- Amyotrophic Lateral Sclerosis (ALS)
- Muscle Regeneration
- Others
Diabetes
Obesity
Cardiovascular
Others

By Service Type

Protocol Designing
Patient Recruitment
Laboratory Services
Site Identification
Bioanalytical Testing Services
- Cell-based Assays
- Virology Testing
- Method Development, Optimization, & Validation
- Serology, Immunogenicity, & Neutralizing Antibodies
- Biomarker Testing Services
- PK/PD (Pharmacokinetics/Pharmacodynamics) Testing Services
- Other Bioanalytical Testing Services
Analytical Testing Services
Clinical Trial Supply & Logistic Services
Clinical Trial Data Management Services
Decentralized Clinical Services
Medical Device Testing Services
Others

By Sponsor

Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Others

By End User

Hospital
Laboratories
Clinics

By Application

Vaccine
Cell & Gene Therapy
Small Molecules
Other Applications

By Geography

North America

U.S.
Canada

Europe

Germany
France
United Kingdom
Rest of Europe

Asia Pacific

China
Japan
India
Southeast Asia
Rest of Asia Pacific

Latin America

Brazil
Rest of Latin America

Middle East & Africa (MEA)

GCC
North Africa
South Africa
Rest of Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global clinical trials market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global clinical trials market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Clinical Trials Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Clinical Trials Market

5.1. Covid-19: Clinical Trials Industry Impact
5.2. Clinical Trials Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Clinical Trials Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Clinical Trials Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Clinical Trials Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing prevalence of chronic disorders
6.1.1.2. Increasing number of clinical trials in developing regions
6.1.2. Market Restraints
6.1.2.1. Rigorous guidelines
6.1.3. Market Opportunities
6.1.3.1. Increasing demand for advanced treatments such as personalized medicines
6.1.3.2. Technological advancements

Chapter 7. Global Clinical Trials Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Clinical Trials Market Revenue by Market Players (2016 -2019)
7.1.1.2. Clinical Trials Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Phase Portfolio Expansion, Geographic Expansion, Phase Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Clinical Trials Market, By Phase

8.1. Clinical Trials Market, by Phase, 2019 - 2030
8.1.1. Phase 1
8.1.1.1. Market Revenue and Forecast (2019 - 2030)
8.1.2. Phase 2
8.1.2.1. Market Revenue and Forecast (2019 - 2030)
8.1.3. Phase 3
8.1.3.1. Market Revenue and Forecast (2019 - 2030)
8.1.4. Phase 4
8.1.4.1. Market Revenue and Forecast (2019 - 2030)

Chapter 9. Global Clinical Trials Market, By Study Design

9.1. Clinical Trials Market, by Study Design, 2019 - 2030
9.1.1. Observational
9.1.1.1. Market Revenue and Forecast (2019 - 2030)
9.1.2. Interventional
9.1.2.1. Market Revenue and Forecast (2019 - 2030)
9.1.3. Expanded Access
9.1.3.1. Market Revenue and Forecast (2019 - 2030)

Chapter 10. Global Clinical Trials Market, By Indication

10.1. Clinical Trials Market, by Indication, 2019 - 2030
10.1.1. Oncology
10.1.1.1. Market Revenue and Forecast (2019 - 2030)
10.1.2. Autoimmune/Inflammation
10.1.2.1. Market Revenue and Forecast (2019 - 2030)
10.1.3. Diabetes
10.1.3.1. Market Revenue and Forecast (2019 - 2030)
10.1.4. Central Nervous System
10.1.4.1. Market Revenue and Forecast (2019 - 2030)
10.1.5. Cardiovascular
10.1.5.1. Market Revenue and Forecast (2019 - 2030)
10.1.6. Pain Management
10.1.7. Market Revenue and Forecast (2019 - 2030)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2019 - 2030)

Chapter 11. Global Clinical Trials Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Phase(2019 - 2030)
11.1.2. Market Revenue Forecast by Study Design(2019 - 2030)
11.1.3. Market Revenue Forecast by Indication (2019 - 2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2019 - 2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2019 - 2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Phase (2019 - 2030)
11.2.2. Market Revenue Forecast by Study Design (2019 - 2030)
11.2.3. Market Revenue Forecast by Indication (2019 - 2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2019 - 2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2019 - 2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2019 - 2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2019 - 2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Phase (2019 - 2030)
11.3.2. Market Revenue Forecast by Study Design (2019 - 2030)
11.3.3. Market Revenue Forecast by Indication (2019 - 2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2019 - 2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2019 - 2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2019 - 2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2019 - 2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Phase (2019 - 2030)
11.4.2. Market Revenue Forecast by Study Design (2019 - 2030)
11.4.3. Market Revenue Forecast by Indication (2019 - 2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2019 - 2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2019 - 2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Phase (2019 - 2030)
11.5.2. Market Revenue Forecast by Study Design (2019 - 2030)
11.5.3. Market Revenue Forecast by Indication (2019 - 2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2019 - 2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2019 - 2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2019 - 2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2019 - 2030)

Chapter 12. Company Profiles

12.1. Parexel
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Phase Portfolio Analysis
12.1.2.1. Product Details, Specification, Indication
12.1.3. Revenue, Price, and Gross Margin (2019 - 2020)
12.1.4. Recent Developments and Strategies
12.2. IQVIA
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Phase Portfolio Analysis
12.2.2.1. Product Details, Specification, Indication
12.2.3. Revenue, Price, and Gross Margin (2019 - 2020)
12.2.4. Recent Developments and Strategies
12.3. Charles River Laboratory
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Phase Portfolio Analysis
12.3.2.1. Product Details, Specification, Indication
12.3.3. Revenue, Price, and Gross Margin (2019 - 2020)
12.3.4. Recent Developments and Strategies
12.4. Omnicare
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Phase Portfolio Analysis
12.4.2.1. Product Details, Specification, Indication
12.4.3. Revenue, Price, and Gross Margin (2019 - 2020)
12.4.4. Recent Developments and Strategies
12.5. Kendle
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Phase Portfolio Analysis
12.5.2.1. Product Details, Specification, Indication
12.5.3. Revenue, Price, and Gross Margin (2019 - 2020)
12.5.4. Recent Developments and Strategies
12.6. Chiltern
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Phase Portfolio Analysis
12.6.2.1. Product Details, Specification, Indication
12.6.3. Revenue, Price, and Gross Margin (2019 - 2020)
12.6.4. Recent Developments and Strategies
12.7. Pharmaceutical Product Development, LLC
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Phase Portfolio Analysis
12.7.2.1. Product Details, Specification, Indication
12.7.3. Revenue, Price, and Gross Margin (2019 - 2020)
12.7.4. Recent Developments and Strategies
12.8. Company 8
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Phase Portfolio Analysis
12.8.2.1. Product Details, Specification, Indication
12.8.3. Revenue, Price, and Gross Margin (2019 - 2020)
12.8.4. Recent Developments and Strategies
12.9. Company 9
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Phase Portfolio Analysis
12.9.2.1. Product Details, Specification, Indication
12.9.3. Revenue, Price, and Gross Margin (2019 - 2020)
12.9.4. Recent Developments and Strategies
12.10. Company 10
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Phase Portfolio Analysis
12.10.2.1. Product Details, Specification, Indication
12.10.3. Revenue, Price, and Gross Margin (2019 - 2020)
12.10.4. Recent Developments and Strategies